Full-Time

Corporate FP&A Senior Manager

Deadline 4/10/27
Mercalis

Mercalis

1,001-5,000 employees

Life sciences commercialization, analytics, and partnerships

No salary listed

Morrisville, NC, USA

In Person

Category
Finance & Banking (1)
Required Skills
Forecasting
Excel/Numbers/Sheets
Financial Modeling
Requirements
  • 7+ years of experience in FP&A, corporate finance, or accounting
  • Strong experience leading corporate financial reporting and forecasting processes, including developing and maintaining all three financial statements
  • Demonstrated experience preparing Board, executive, and investor-level financial presentations
  • Proven experience building and maintaining three-statement financial models and Free Cash Flow forecasts
  • Strong understanding of working capital drivers and cash flow dynamics
  • Advanced Excel and financial modeling capabilities
  • Exceptional ability to translate financial analysis into clear executive presentations and business insights
Responsibilities
  • Lead the monthly financial reporting process across the company
  • Produce the internal Financial Review Package (FRP) summarizing company financial performance and go beyond reporting to highlight margin expansion ideas
  • Prepare and maintain Monthly Operating Review (MOR) materials for executive leadership
  • Develop and maintain Board reporting materials, ensuring clear and actionable financial insights
  • Translate complex financial results into clear executive-level narratives and presentations
  • Provide department financial reporting and analysis for corporate OPEX and COGS functions not covered by BU finance leads
  • Own headcount reporting, including tracking, forecasting, and reconciliation with operating plans
  • Prepare financial reporting packages for lenders and financing partners and flag any covenant noncompliance concerns
  • Maintain single source of truth for actual results
  • Lead the monthly forecast consolidation process across business units and corporate functions
  • Own development and maintenance of three-statement forecasting, including: Profit & Loss; Balance Sheet; Cash Flow Statement
  • Develop and maintain Free Cash Flow (FCF) forecasting, including working capital drivers, capital expenditures, and cash conversion dynamics
  • Own and maintain the company’s corporate financial model, ensuring accurate forecasting of operating performance, balance sheet impacts, and Free Cash Flow generation
  • Partner closely with accounting to ensure alignment between operational forecasts and financial statement projections
  • Coordinate the annual budgeting process, including timeline management, consolidation, and executive review materials
  • Keep a consolidated list of risks and opportunities from BU leads or others, and proactively flag them before they occur
  • Ad hoc reporting/ analysis at the request of the head of FP&A or CFO
Desired Qualifications
  • CPA designation preferred
  • Experience implementing or managing FP&A planning tools (Anaplan, Adaptive, Planful, Pigment, etc.)
  • Experience with NetSuite
  • Experience in PE-backed or high-growth environments
  • Pharma services or healthcare services industry experience

Mercalis provides commercialization services for life sciences and pharmaceutical companies. It uses data analytics, industry expertise, and technology to maximize value across both product and patient journeys, guiding from value discovery to delivery. Its offerings include insights, strategy, data, and solutions that help life sciences leaders address critical business issues and support strategic decision-making. The company also connects patients with life sciences products and programs through data-driven access initiatives, and it conducts scalable outreach to healthcare providers to generate leads, educate, and engage across the provider value chain. By focusing on partnerships with life sciences companies, Mercalis aims to unlock product value and improve patient lives.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Morrisville, North Carolina

Founded

N/A

Simplify Jobs

Simplify's Take

What believers are saying

  • PharmaCord merger enhances patient access with combined expertise.
  • U.S. court vacated 2023 CMS rule, preserving copay programs.
  • Philanthropic partnerships boost Mercalis's community reputation.

What critics are saying

  • PharmaCord integration fails, cutting staff and service quality in 6-12 months.
  • IQVIA One Home diverts 20-30% of contracts in 12-18 months.
  • CoverMyMeds blocks eServices growth, halving new clients in 12-24 months.

What makes Mercalis unique

  • Mercalis integrates Policy Reporter for real-time market access data.
  • Mercalis combines patient services with advanced commercialization technology.
  • Mercalis rebranded from TrialCard, serving 500+ life sciences customers since 2000.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Mercalis who can refer or advise you

Benefits

Remote Work Options

Professional Development Budget

Training Programs

Company News

PR Newswire
Apr 3rd, 2025
Triangle Insights Group By Mercalis Announces Promotion Of Parker Guse

Premier life sciences consulting firm promotes Senior Principal to PartnerDURHAM, N.C., April 3, 2025 /PRNewswire/ -- Triangle Insights Group by Mercalis (Triangle), a premier strategy consulting firm that delivers high-impact solutions across the life sciences value chain, today announced a promotion that recognizes high achievement and further strengthens the firm's senior leadership team. Triangle, acquired by life sciences commercialization company Mercalis in April 2022, has named Parker Guse a Partner.Guse, who joined Triangle in June 2014, has over a decade of experience in the life sciences industry. In his role, Parker leads Triangle's business development and corporate strategy center of excellence. He has extensive experience in both buy-side and sell-side diligence that spans pharma, biotech, and private equity clients. His typical projects include due diligence, commercial assessment, and portfolio and commercialization strategy. Guse has been involved in over 300 projects spanning all therapeutic areas, with a focus on oncology, autoimmune disorders, and rare diseases.Guse holds a BA in Economics from the University of North Carolina at Chapel Hill."Parker has made invaluable contributions to Triangle's success throughout his years at the firm," said Megan Thomas, Triangle's General Manager

Business Wire
Mar 13th, 2025
PharmaCord and Mercalis to Merge, Creating Next-Generation Platform to Meet Evolving Needs of the Biopharmaceutical Industry

PharmaCord LLC (“PharmaCord”), a leading provider of patient services for the biopharmaceutical industry, and Mercalis, an integrated life sciences co

Permira
Mar 12th, 2025
PharmaCord and Mercalis to Merge, Creating Next-Generation Platform to Meet Evolving Needs of the Biopharmaceutical Industry

By combining PharmaCord's expertise in patient services with Mercalis's advanced technology infrastructure, experienced commercial team, and fully integrated market access offerings, the new entity is poised to be a leading provider of patient access solutions to the biopharmaceutical industry.